Protective Role of Dimethyltryptamine in Preserving Donor Heart Function in a Heterotopic Rat Transplantation Model
This study demonstrates that supplementing the preservation solution with N,N-Dimethyltryptamine (DMT) and administering it to donors and recipients significantly improves early graft function and reduces cellular stress in a rat heterotopic heart transplantation model, likely through the modulation of mitochondrial, metabolic, and stress-response pathways.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine the human heart as a high-performance race car engine. When a car breaks down beyond repair, the only way to keep the driver moving is to swap in a brand-new engine from a donor. But here's the tricky part: before that new engine can be installed, it has to be taken out, packed up, and shipped in a cold box. During this journey, the engine sits in the dark without fuel or oxygen. This "cold storage" is like leaving a race car sitting in a freezing garage for an hour; when you finally try to start it up again, the sudden rush of air and fuel can cause a massive, damaging explosion inside the cylinders. In medical terms, this is called "ischemia–reperfusion injury." It's the main reason why some donated hearts struggle or fail right after the surgery. Scientists have been searching for a "magic shield"—a simple chemical that could be added to the cold storage fluid to wrap the heart in a protective bubble, stopping that explosion before it happens. One such chemical is Dimethyltryptamine, or DMT. You might know DMT as a substance found in nature that can cause hallucinations, but in this story, we aren't talking about trips; we are talking about a tiny molecule that acts like a bodyguard for cells, potentially helping them survive the stress of being turned off and then suddenly turned back on.
In this study, a team of researchers decided to test if this "bodyguard" molecule could save a donor heart in a rat experiment. They set up a scenario where they took hearts from one group of rats, kept them cold for exactly 60 minutes, and then swapped them into other rats. The control group used standard cold fluid, while the experimental group used the same fluid but with DMT added to it. They also gave a dose of DMT to the rats before the surgery and to the rats receiving the new heart. After the hearts were back in the body and pumping for 60 minutes, the scientists measured how well they worked.
The results were quite promising for the DMT group. The hearts treated with DMT pumped with more force and showed a strong trend toward relaxing faster than the ones in the standard fluid, though the overall statistical proof for the relaxation speed was a bit mixed. Specifically, the pressure inside the left ventricle (the main pumping chamber) was significantly higher, and the speed at which the heart muscle could squeeze was improved. It was as if the DMT-treated engines revved up more smoothly and powerfully than the standard ones. However, the story isn't a simple "DMT fixes everything." When the scientists looked for signs of damage or inflammation in the blood, they found no difference between the two groups. The DMT hearts didn't show lower levels of injury markers like troponin or inflammatory signals like TNF-α. This suggests that DMT didn't necessarily stop the heart from getting a little bruised; instead, it seemed to help the heart function better despite the stress, almost like tuning the engine to run more efficiently even if the parts were slightly worn.
Digging deeper into the cells, the researchers found that DMT changed the activity of specific genes related to how cells handle stress and oxygen. The treated hearts showed changes in genes like Hif1a and Ddit3, which are involved in how cells react to low oxygen and internal stress. Interestingly, the study found a trend toward elevated levels of a protein called "cleaved caspase-3" in the DMT group, which is a signal that tells a cell to self-destruct, though this didn't quite reach the strict statistical threshold for being "proven" in this specific experiment. The study also noted that the DMT hearts had a statistically significant increase in the staining scores for a protein called p62, which is linked to how cells clean up their own trash. However, the researchers warn that interpreting this increase is complex; depending on the context, higher p62 could mean the cells are tagging more trash for cleanup, or it could mean the cleanup process itself is getting clogged.
The researchers are careful to point out that this was a short-term test. They only watched the hearts for 60 minutes after the transplant. While the hearts performed better in that short window, they don't know yet if this advantage lasts for days, weeks, or years, or if it changes the long-term health of the heart. They also used a rat model, which is great for learning the basics, but rats are not humans, so we can't say for sure this will work the same way in people just yet.
In short, this paper suggests that adding DMT to the preservation fluid and treating the animals with it might give a donor heart a "functional boost," helping it pump stronger and showing signs of better relaxation right after surgery. It appears to work by tweaking the heart's internal stress responses rather than by completely preventing injury. While it's not a guaranteed cure-all, and more research is needed to see if these benefits stick around longer, it offers a fascinating new hint that a molecule known for its psychedelic reputation might have a serious, life-saving side to its personality.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.